Sign Up to like & get
recommendations!
1
Published in 2020 at "Current opinion in immunology"
DOI: 10.1016/j.coi.2020.10.002
Abstract: Non-type 2 inflammation (Non-T2)-mediated asthma is difficult to define due to lack of signature biomarkers. It exists in the absence of T2-high or eosinophilic inflammation and includes neutrophilic and paucigranulocytic subtypes. Several cell types and…
read more here.
Keywords:
type asthma;
inflammation;
non asthma;
non type ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2020.107309
Abstract: Background COVID-19 is considered the most critical health pandemic of 21st century. Due to extremely high transmission rate, people are more susceptible to viral infection. COVID-19 patients having chronic type-2 asthma prevails a major risk…
read more here.
Keywords:
type asthma;
covid;
review;
covid type ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "American journal of respiratory cell and molecular biology"
DOI: 10.1165/rcmb.2021-0364oc
Abstract: Asthma is associated with chronic changes in the airway epithelium, a key target of SARS-CoV-2. Many epithelial changes, including goblet cell metaplasia, are driven by the type 2 cytokine IL-13, but the effects of IL-13…
read more here.
Keywords:
type asthma;
cov infection;
cell;
sars cov ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of immunology"
DOI: 10.4049/jimmunol.2200288
Abstract: IL-17A plays an important role in the pathogenesis of asthma, particularly the neutrophilic corticosteroid (CS)-resistant subtype of asthma. Clinical studies suggest that a subset of asthma patients, i.e., Th17/IL-17A-mediated (type 17) CS-resistant neutrophilic asthma, may…
read more here.
Keywords:
lcn2 saa;
mechanisms corticosteroid;
asthma;
type ... See more keywords